Works by Rosenstock, Julio

Results: 310
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Editorial Cycles and Continuity of Diabetes Care.

    Published in:
    2022
    By:
    • Riddle, Matthew C.;
    • Bakris, George;
    • Blonde, Lawrence;
    • Boulton, Andrew J.M.;
    • Castle, Jessica;
    • DiMeglio, Linda;
    • Gonder-Frederick, Linda;
    • Hu, Frank;
    • Kahn, Steven;
    • Kaul, Sanjay;
    • Moses, Robert;
    • Rich, Stephen;
    • Rosenstock, Julio;
    • Selvin, Elizabeth;
    • Vella, Adrian;
    • Wylie-Rosett, Judith;
    • with and on behalf of Associate Editors Vanita Aroda
    Publication type:
    Editorial
    11
    12
    13

    Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial.

    Published in:
    2021
    By:
    • Rosenstock, Julio;
    • Emral, Rifat;
    • Sauque-Reyna, Leobardo;
    • Mohan, Viswanathan;
    • Trescoli, Carlos;
    • Al Sifri, Saud;
    • Lalic, Nebojsa;
    • Alvarez, Agustina;
    • Picard, Pascaline;
    • Bonnemaire, Mireille;
    • Demil, Nacima;
    • McCrimmon, Rory J.;
    • Trescolí, Carlos;
    • Sifri, Saud Al;
    • SoliMix Trial Investigators
    Publication type:
    journal article
    14
    15
    16
    17
    18
    19
    20

    A Lesson From 2020: Public Health Matters for Both COVID-19 and Diabetes.

    Published in:
    2021
    By:
    • Riddle, Matthew C.;
    • Bakris, George;
    • Blonde, Lawrence;
    • Boulton, Andrew J.M.;
    • D'Alessio, David;
    • DiMeglio, Linda A.;
    • Gonder-Frederick, Linda;
    • Hood, Korey K.;
    • Hu, Frank B.;
    • Kahn, Steven E.;
    • Kaul, Sanjay;
    • Leiter, Lawrence A.;
    • Moses, Robert G.;
    • Rich, Stephen S.;
    • Rosenstock, Julio;
    • Wylie-Rosett, Judith
    Publication type:
    Editorial
    21
    22

    Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial.

    Published in:
    2020
    By:
    • Perkovic, Vlado;
    • Toto, Robert;
    • Cooper, Mark E.;
    • Mann, Johannes F.E.;
    • Rosenstock, Julio;
    • McGuire, Darren K.;
    • Kahn, Steven E.;
    • Marx, Nikolaus;
    • Alexander, John H.;
    • Zinman, Bernard;
    • Pfarr, Egon;
    • Schnaidt, Sven;
    • Meinicke, Thomas;
    • von Eynatten, Maximillian;
    • George, Jyothis T.;
    • Johansen, Odd Erik;
    • Wanner, Christoph;
    • CARMELINA investigators
    Publication type:
    journal article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Big Topics for in 2018: Clinical Guidelines, Costs of Diabetes, and Information Technology.

    Published in:
    Diabetes Care, 2018, v. 41, n. 7, p. 1327, doi. 10.2337/dci18-0035
    By:
    • Riddle, Matthew C.;
    • Bakris, George;
    • Boulton, Andrew J. M.;
    • Blonde, Lawrence;
    • D'Alessio, David;
    • Greene, Eddie L.;
    • de Groot, Mary;
    • Hood, Korey;
    • Hu, Frank B.;
    • Kahn, Steven E.;
    • Kaul, Sanjay;
    • Le Roith, Derek;
    • Moses, Robert G.;
    • Rich, Stephen S.;
    • Rosenstock, Julio;
    • Tamborlane, William V.;
    • Wylie-Rosett, Judith;
    • Reynolds, Lyn
    Publication type:
    Article
    37
    38
    39
    40
    41
    42

    Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980

    Published in:
    2017
    By:
    • Aroda, Vanita R;
    • Rosenstock, Julio;
    • Wysham, Carol;
    • Unger, Jeffrey;
    • Bellido, Diego;
    • González-Gálvez, Guillermo;
    • Takami, Akane;
    • Guo, Hailing;
    • Niemoeller, Elisabeth;
    • Souhami, Elisabeth;
    • Bergenstal, Richard M;
    • LixiLan-L Trial Investigators
    Publication type:
    journal article
    43

    Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035.

    Published in:
    2017
    By:
    • Rosenstock, Julio;
    • Aronson, Ronnie;
    • Grunberger, George;
    • Hanefeld, Markolf;
    • Piatti, PierMarco;
    • Serusclat, Pierre;
    • Cheng, Xi;
    • Zhou, Tianyue;
    • Niemoeller, Elisabeth;
    • Souhami, Elisabeth;
    • Davies, Melanie;
    • LixiLan-O Trial Investigators
    Publication type:
    journal article
    44
    45
    46
    47

    Diabetes Care: "Taking It to the Limit One More Time".

    Published in:
    2017
    By:
    • Cefalu, William T.;
    • Boulton, Andrew J. M.;
    • Tamborlane, William V.;
    • Moses, Robert G.;
    • LeRoith, Derek;
    • Greene, Eddie L.;
    • Hu, Frank B.;
    • Bakris, George;
    • Wylie-Rosett, Judith;
    • Rosenstock, Julio;
    • Kahn, Steven E.;
    • Weinger, Katie;
    • Blonde, Lawrence;
    • de Groot, Mary;
    • Rich, Stephen;
    • D'Alessio, David;
    • Reynolds, Lyn;
    • Riddle, Matthew C.
    Publication type:
    Editorial
    48

    Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial.

    Published in:
    2016
    By:
    • Aroda, Vanita R.;
    • Rosenstock, Julio;
    • Wysham, Carol;
    • Unger, Jeffrey;
    • Bellido, Diego;
    • Gonzáalez-Gálvez, Guillermo;
    • Takami, Akane;
    • Hailing Guo;
    • Niemoeller, Elisabeth;
    • Souhami, Elisabeth;
    • Bergenstal, Richard M.;
    • González-Gálvez, Guillermo;
    • Guo, Hailing;
    • LixiLan-L Trial Investigators
    Publication type:
    journal article
    49

    Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial.

    Published in:
    2016
    By:
    • Rosenstock, Julio;
    • Aronson, Ronnie;
    • Grunberger, George;
    • Hanefeld, Markolf;
    • Piatti, PierMarco;
    • Serusclat, Pierre;
    • Xi Cheng;
    • Tianyue Zhou;
    • Niemoeller, Elisabeth;
    • Souhami, Elisabeth;
    • Davies, Melanie;
    • Cheng, Xi;
    • Zhou, Tianyue;
    • LixiLan-O Trial Investigators
    Publication type:
    journal article
    50